TipRanks
Demant A/S (MX:DEMANTN)
:DEMANTN
Mexico Market

Demant (DEMANTN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

DEMANTN Analyst Ratings

Moderate Buy
8Ratings
Moderate Buy
4 Buy
4 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Demant
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DEMANTN Stock 12 Month Forecast

Average Price Target

―
Based on 8 Wall Street analysts offering 12 month price targets for Demant in the last 3 months. The average price target is $886.05 with a high forecast of $1,117.41 and a low forecast of $744.94. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$1,117Average Price Target$886.05Lowest Price Target$744.94
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:DEMANTN
Goldman Sachs
Goldman Sachs
$1,048.43→$1,117.41
Buy
―
Reiterated
10/12/26
Goldman Sachs Sticks to Their Buy Rating for Demant (WILLF)
Barclays
$744.94
Hold
―
Reiterated
10/02/26
Barclays Sticks to Their Hold Rating for Demant (WILLF)
Morgan Stanley Analyst forecast on MX:DEMANTN
Morgan Stanley
Morgan Stanley
$816.68→$1,070.51
Buy
―
Reiterated
09/02/26
Morgan Stanley Sticks to Their Buy Rating for Demant (WILLF)
Jefferies
$800.12→$951.87
Buy
―
Reiterated
08/20/26
Jefferies Reaffirms Their Buy Rating on Demant (WILLF)
Bernstein
$761.49
Hold
―
Reiterated
08/14/26
Bernstein Remains a Hold on Demant (WILLF)
Citi
―
Buy
―
Reiterated
08/14/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (NASDAQ: ACHV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Demant (Other OTC: WILLF)
Danske Bank Analyst forecast on MX:DEMANTN
Unknown Analyst
Danske Bank
Not Ranked
Danske Bank
$772.53
Hold
―
Downgraded
08/06/26
Demant downgraded to Hold from Buy at Danske BankDemant downgraded to Hold from Buy at Danske Bank
UBS
$753.22→$783.57
Hold
―
Downgraded
07/22/26
Demant downgraded to Neutral from Buy at UBSDemant downgraded to Neutral from Buy at UBS
Deutsche Bank  Analyst forecast on MX:DEMANTN
Deutsche Bank
Deutsche Bank
$623.54→$711.83
Hold
―
Reiterated
07/06/26
Demant price target raised to DKK 258 from DKK 226 at Deutsche BankDemant price target raised to DKK 258 from DKK 226 at Deutsche Bank
Bank of America Securities Analyst forecast on MX:DEMANTN
Bank of America Securities
Bank of America Securities
$469.04→$772.53
Buy
―
Upgraded
06/09/26
Demant upgraded to Buy from Underperform at BofADemant upgraded to Buy from Underperform at BofA
Nordea Markets Analyst forecast on MX:DEMANTN
Nordea Markets
Nordea Markets
$634.58
Buy
―
Upgraded
02/18/26
Demant upgraded to Buy from Hold at NordeaDemant upgraded to Buy from Hold at Nordea
Exane BNP Paribas Analyst forecast on MX:DEMANTN
Andjela Bozinovic
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$551.81
Hold
―
Downgraded
02/06/26
Demant downgraded to Neutral from Outperform at BNP ParibasDemant downgraded to Neutral from Outperform at BNP Paribas
J.P. Morgan Analyst forecast on MX:DEMANTN
J.P. Morgan
J.P. Morgan
$794.6→$689.76
Buy
―
Reiterated
02/04/26
Demant price target lowered to DKK 250 from DKK 288 at JPMorganDemant price target lowered to DKK 250 from DKK 288 at JPMorgan
Wolfe Research Analyst forecast on MX:DEMANTN
Wolfe Research
Wolfe Research
$855.3→$736.66
Buy
―
Reiterated
10/14/25
Morgan Stanley Remains a Buy on Demant (WILLF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:DEMANTN
Goldman Sachs
Goldman Sachs
$1,048.43→$1,117.41
Buy
―
Reiterated
10/12/26
Goldman Sachs Sticks to Their Buy Rating for Demant (WILLF)
Barclays
$744.94
Hold
―
Reiterated
10/02/26
Barclays Sticks to Their Hold Rating for Demant (WILLF)
Morgan Stanley Analyst forecast on MX:DEMANTN
Morgan Stanley
Morgan Stanley
$816.68→$1,070.51
Buy
―
Reiterated
09/02/26
Morgan Stanley Sticks to Their Buy Rating for Demant (WILLF)
Jefferies
$800.12→$951.87
Buy
―
Reiterated
08/20/26
Jefferies Reaffirms Their Buy Rating on Demant (WILLF)
Bernstein
$761.49
Hold
―
Reiterated
08/14/26
Bernstein Remains a Hold on Demant (WILLF)
Citi
―
Buy
―
Reiterated
08/14/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (NASDAQ: ACHV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Demant (Other OTC: WILLF)
Danske Bank Analyst forecast on MX:DEMANTN
Unknown Analyst
Danske Bank
Not Ranked
Danske Bank
$772.53
Hold
―
Downgraded
08/06/26
Demant downgraded to Hold from Buy at Danske BankDemant downgraded to Hold from Buy at Danske Bank
UBS
$753.22→$783.57
Hold
―
Downgraded
07/22/26
Demant downgraded to Neutral from Buy at UBSDemant downgraded to Neutral from Buy at UBS
Deutsche Bank  Analyst forecast on MX:DEMANTN
Deutsche Bank
Deutsche Bank
$623.54→$711.83
Hold
―
Reiterated
07/06/26
Demant price target raised to DKK 258 from DKK 226 at Deutsche BankDemant price target raised to DKK 258 from DKK 226 at Deutsche Bank
Bank of America Securities Analyst forecast on MX:DEMANTN
Bank of America Securities
Bank of America Securities
$469.04→$772.53
Buy
―
Upgraded
06/09/26
Demant upgraded to Buy from Underperform at BofADemant upgraded to Buy from Underperform at BofA
Nordea Markets Analyst forecast on MX:DEMANTN
Nordea Markets
Nordea Markets
$634.58
Buy
―
Upgraded
02/18/26
Demant upgraded to Buy from Hold at NordeaDemant upgraded to Buy from Hold at Nordea
Exane BNP Paribas Analyst forecast on MX:DEMANTN
Andjela Bozinovic
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
$551.81
Hold
―
Downgraded
02/06/26
Demant downgraded to Neutral from Outperform at BNP ParibasDemant downgraded to Neutral from Outperform at BNP Paribas
J.P. Morgan Analyst forecast on MX:DEMANTN
J.P. Morgan
J.P. Morgan
$794.6→$689.76
Buy
―
Reiterated
02/04/26
Demant price target lowered to DKK 250 from DKK 288 at JPMorganDemant price target lowered to DKK 250 from DKK 288 at JPMorgan
Wolfe Research Analyst forecast on MX:DEMANTN
Wolfe Research
Wolfe Research
$855.3→$736.66
Buy
―
Reiterated
10/14/25
Morgan Stanley Remains a Buy on Demant (WILLF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
ASNDAscendis Pharma
QNCXQuince Therapeutics
EHCEncompass Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Demant

3 Months
Richard FeltonGoldman Sachs
Success Rate
6/8 ratings generated profit
75%
Average Return
+9.04%
Copying Richard Felton's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +9.04% per trade.
1 Year
Success Rate
9/10 ratings generated profit
90%
Average Return
+22.83%
Copying Veronika Dubajova's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +22.83% per trade.
2 Years
Richard FeltonGoldman Sachs
Success Rate
8/8 ratings generated profit
100%
Average Return
+34.11%
Copying Richard Felton's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +34.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DEMANTN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
7
7
9
7
7
Hold
6
7
8
6
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
14
17
13
11
In the current month, DEMANTN has received 7 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. DEMANTN average Analyst price target in the past 3 months is 886.05.
Each month's total comprises the sum of three months' worth of ratings.

DEMANTN Financial Forecast

DEMANTN Earnings Forecast

Next quarter’s earnings estimate for DEMANTN is $20.98 with a range of $19.87 to $21.96. The previous quarter’s EPS was $17.66. DEMANTN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DEMANTN has Performed in-line its overall industry.
Next quarter’s earnings estimate for DEMANTN is $20.98 with a range of $19.87 to $21.96. The previous quarter’s EPS was $17.66. DEMANTN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DEMANTN has Performed in-line its overall industry.

DEMANTN Sales Forecast

Next quarter’s sales forecast for DEMANTN is $37.26B with a range of $35.86B to $38.42B. The previous quarter’s sales results were $35.81B. DEMANTN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DEMANTN has Performed in-line its overall industry.
Next quarter’s sales forecast for DEMANTN is $37.26B with a range of $35.86B to $38.42B. The previous quarter’s sales results were $35.81B. DEMANTN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DEMANTN has Performed in-line its overall industry.

DEMANTN Stock Forecast FAQ

What is MX:DEMANTN’s average 12-month price target, according to analysts?
Based on analyst ratings, Demant A/S’s 12-month average price target is 886.05.
    What is MX:DEMANTN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:DEMANTN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Demant A/S a Buy, Sell or Hold?
        Demant A/S has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Demant A/S’s share price target?
          The average share price target for Demant A/S is 886.05. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,117.41 ,and the lowest forecast is $744.94. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Demant A/S?
            Demant A/S’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
              How can I buy shares of Demant A/S?
              To buy shares of MX:DEMANTN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.